Search results for "energi"

showing 10 items of 1725 documents

Modulation of adrenergic responses of human vas deferens by K+ channel inhibitors.

2010

Objectives The present study was designed to evaluate the role of K + channels in the adrenergic responses of human vas deferens as well as the intervention of dihydropyridine-sensitive Ca 2+ channels on modulation of adrenergic responses by K + channel inhibitors. Methods Ring segments of the epididymal part of the vas deferens were taken from 32 elective vasectomies and mounted in organ baths for isometric recording of tension. We then studied the effects of K + channel blockers on neurogenic and norepinephrine-induced contractile responses. Results Addition of tetraethylammonium (TEA, 10 −3 M), a nonspecific K + channel blocker, or charybdotoxin (10 −7 M), a nonselective inhibitor of lar…

AdultMalemedicine.medical_specialtyPotassium ChannelsCharybdotoxinCalcium Channels L-TypeCharybdotoxinNifedipineUrologyAdrenergicApaminGlibenclamidechemistry.chemical_compoundNorepinephrineVas DeferensNifedipineInternal medicineReceptors Adrenergic alpha-1GlyburidePotassium Channel BlockersMedicineHumansChannel blockerTetraethylammoniumIon Transportbusiness.industryVas deferensTetraethylammoniumMuscle SmoothElectric StimulationEndocrinologymedicine.anatomical_structurechemistryApaminPotassiumCalciumbusinessPeptidesmedicine.drugMuscle ContractionUrology
researchProduct

Clonidine induces nitric oxide- and prostaglandin-mediated vasodilation in healthy human skin

2005

Sustained sympathetic activation not only leads to vasoconstriction but also might induce paradox vasodilation. This study was performed to explore whether and how alpha(2)-receptor stimulation mediates this vasodilation. We investigated 11 healthy subjects in 33 dermal microdialysis (MD) sessions. After nerve trunk blockade, MD fibers were inserted and perfused with physiological saline until skin trauma-related vasodilation subsided. Thereafter, fibers were perfused with either clonidine solutions (10(-3), 5 x 10(-4), 10(-4) mol/l), N(G)-monomethyl-l-arginine (L-NMMA; nitric oxide synthase blocker), acetylsalicylic acid (ASA; cyclooxygenase blocker), or combinations of these. Laser-Dopple…

AdultMalemedicine.medical_specialtySympathetic nervous systemPhysiologyImidazoline receptorProstaglandinVasodilationStimulationNitric OxideClonidineNitric oxidechemistry.chemical_compoundReference ValuesSkin Physiological PhenomenaPhysiology (medical)Internal medicineAdrenergic alpha-2 Receptor AgonistsmedicineHumansSkinDose-Response Relationship DrugChemistryVasodilationEndocrinologymedicine.anatomical_structureEicosanoidProstaglandinsmedicine.symptomAdrenergic alpha-AgonistsBlood Flow VelocityVasoconstrictionJournal of Applied Physiology
researchProduct

Effects of Nebivolol versus Carvedilol on Left Ventricular Function in Patients with Chronic Heart Failure and Reduced Left Ventricular Systolic Func…

2006

Beta-adrenoceptor antagonist (beta-blocker) therapy results in a significant improvement in left ventricular (LV) systolic function and prognosis in patients with chronic heart failure. Both carvedilol and nebivolol produce hemodynamic and clinical benefits in chronic heart failure, but it is unknown whether their peculiar pharmacologic properties produce different effects on LV function.To assess the effects on LV function of nebivolol compared with carvedilol in patients with chronic heart failure and reduced LV systolic function.Seventy patients with a LV ejection fractionor=40% and in New York Heart Association (NYHA) functional class II or III were randomly assigned to receive carvedil…

AdultMalemedicine.medical_specialtySystoleAdrenergic beta-AntagonistsCarbazolesHemodynamicsVentricular Function LeftNebivololPropanolaminesElectrocardiographyHeart RateInternal medicineHeart rateHumansMedicineBenzopyransPharmacology (medical)SystoleCarvedilolAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseNebivololEthanolaminesHeart failureCardiologyCarvedilolFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographymedicine.drugAmerican Journal of Cardiovascular Drugs
researchProduct

Body weight changes and the A-6G polymorphism of the angiotensinogen gene

2002

BACKGROUND: The objective of the study was to analyze the relationship of polymorphisms of the angiotensinogen gene with changes in body weight during 3 y of antihypertensive treatment, in a group of young adults with essential hypertension. METHODS: Essential hypertensives, less than 50 y old, never previously treated with antihypertensive drugs and in the absence of diabetes mellitus were included. After the initial evaluation, patients were treated using only non-pharmacological measures (n=29), β-blockers (n=40) or angiotensin-converting enzyme inhibitors (n=66). Resting blood pressure, biochemical profile and body weight at the beginning and yearly were measured. The polymorphism A-6G …

AdultMalemedicine.medical_specialtyTime FactorsGenotypeEndocrinology Diabetes and MetabolismAdrenergic beta-AntagonistsAngiotensinogenMedicine (miscellaneous)Angiotensin-Converting Enzyme InhibitorsEssential hypertensionBody Mass IndexGene FrequencyPolymorphism (computer science)Diabetes mellitusInternal medicineGenotypeHumansMedicineAllele frequencyAntihypertensive AgentsAnalysis of VariancePolymorphism GeneticNutrition and Dieteticsbusiness.industryBody WeightMiddle Agedmedicine.diseaseBlood pressureEndocrinologyHypertensionFemalemedicine.symptombusinessBody mass indexWeight gainFollow-Up StudiesInternational Journal of Obesity
researchProduct

Prognostic Value of a Comprehensive Cardiac Magnetic Resonance Assessment Soon After a First ST-Segment Elevation Myocardial Infarction

2009

ObjectivesTo evaluate the prognostic value of a comprehensive cardiac magnetic resonance (CMR) assessment soon after a first ST-segment elevation myocardial infarction (STEMI).BackgroundCMR allows for a simultaneous assessment of wall motion abnormalities (WMA), WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI. Its prognostic value and the relative prognostic weight of these indexes are not well-defined.MethodsWe studied 214 consecutive patients with a first STEMI treated with thrombolytic therapy or primary angioplasty discharged from hospital. In …

AdultMalemedicine.medical_specialtyTime FactorsMagnetic Resonance Imaging CineInfarctionKaplan-Meier EstimateRisk Assessmentcardiac magnetic resonanceNecrosisPredictive Value of TestsRecurrenceRisk FactorsDobutamineInternal medicinemedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsHeart Failurebusiness.industryMyocardiumAdrenergic beta-AgonistsMiddle Agedmedicine.diseaseCoronary VesselsMyocardial ContractionTreatment Outcomemyocardial infarctionRadiology Nuclear Medicine and imagingHeart failureMicrovesselscardiovascular systemCardiologyMyocardial infarction complicationsFemaleDobutamineprognosisMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessTIMIMacemedicine.drugJACC: Cardiovascular Imaging
researchProduct

Enhancement by vasopressin of adrenergic responses in human mesenteric arteries.

1997

Vasopressin not only acts directly on blood vessels through V1-receptor stimulation but also may modulate adrenergic-mediated responses in animal experiments in vitro and in vivo. The aim of the present study was to investigate whether subpressor concentrations of vasopressin could modify the constrictor responses to norepinephrine and electrical stimulation of the perivascular nerves in human mesenteric arteries. Human mesenteric artery rings (3-3.5 mm long, 0.8-1.2 mm OD) were obtained from 38 patients undergoing abdominal operations. The arterial rings were suspended in organ bath chambers for isometric recording of tension. Vasopressin (3 x 10(-11) M) enhanced the contractions elicited…

AdultMalemedicine.medical_specialtyVasopressinPhysiologyVasopressinsNeuropeptideAdrenergicStimulationIn Vitro TechniquesMuscle Smooth VascularPotassium ChlorideNorepinephrine (medication)Calcium ChlorideNorepinephrineHormone AntagonistsNifedipinePhysiology (medical)Internal medicinemedicineHumansMesenteric arteriesAgedbusiness.industryMiddle AgedElectric StimulationMesenteric ArteriesArginine Vasopressinmedicine.anatomical_structureEndocrinologyCatecholamineFemaleCardiology and Cardiovascular MedicinebusinessOmentummedicine.drugMuscle ContractionThe American journal of physiology
researchProduct

Physical dose of therapeutic exercises in institutional neck rehabilitation

2013

Objective: To determine the intensity and volume of therapeutic exercises during a standard 13-day inpatient neck rehabilitation course in relation to overall physical activity in rehabilitation and everyday life. Design: Cross-sectional study. Methods: Subjects (n=19; 16 women and 3 men; mean age 48.6 years, standard deviation (SD) 6.6) with chronic nonspecific neck pain were recruited from two inpatient neck rehabilitation courses. Intensity and volume of therapeutic exercises and physical activity were measured in metabolic equivalents (METs) with an objective measurement device and all-time recall questionnaire. Maximum oxygen uptake was determined in METs (METc) by direct maximal cycle…

AdultMalemedicine.medical_specialtyharjoitusterapiamedicine.medical_treatmentPain reliefphysical activityPilot ProjectsPhysical Therapy Sports Therapy and RehabilitationMotor ActivityMetabolic equivalent03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationMetabolic EquivalentHumansMedicine030212 general & internal medicineNeck painNeck PainRehabilitationbusiness.industryRehabilitationConfoundingVO2 maxGeneral MedicineMiddle Agedmetabolic equivalentExercise TherapyHospitalizationOxygenfyysinen kuntoCross-Sectional StudiesShoulder exercisesTherapeutic exerciseExercise TestPhysical therapyFemaleChronic Painmedicine.symptomenergian kulutusbusiness030217 neurology & neurosurgeryfyysinen aktiivisuusliikuntahoito
researchProduct

Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics.

2005

Background:  Several in vitro studies demonstrate that corticosteroids and long-acting β2 agonists may have a complementary and synergistic mode of action on the inflammatory processes in asthma. Methods:  Sputum was induced in 20 mild to moderate asthmatic patients and the induced sputum cells (ISC) were cultured with beclomethasone dipropionate (BDP) 10−7 M, salbutamol 10−8 M and formoterol 10−8 M either alone or in combination, BDP plus salbutamol and BDP plus formoterol, for 24 h. We measured the levels of growth macrophages-colony stimulating factor (GM-CSF), released on activation normal T cells expressed and activated (RANTES) and interleukin-8 (IL-8), in the supernatant of stimulate…

AdultMalemedicine.medical_specialtymedicine.drug_classReceptor expressionImmunologySeverity of Illness IndexGlucocorticoid receptorReceptors GlucocorticoidInternal medicineFormoterol FumaratemedicineImmunology and AllergyHumansAlbuterolDrug InteractionsTissue DistributionAnti-Asthmatic AgentsChemokine CCL5Cells Culturedbusiness.industryInterleukin-8BeclomethasoneSputumGranulocyte-Macrophage Colony-Stimulating FactorBeclometasone dipropionaterespiratory systemMiddle AgedAsthmarespiratory tract diseasesBronchodilator AgentsEndocrinologyEthanolaminesSalbutamolCorticosteroidFormoterol FumarateDrug Therapy CombinationFemaleFormoterolReceptors Adrenergic beta-2businessEx vivomedicine.drugAllergy
researchProduct

Effects of β-adrenergic blockade on EMG signal characteristics during progressive exercise

1984

AdultMalemedicine.medical_specialtyβ adrenergic blockademedicine.diagnostic_testElectromyographyPhysiologyBlocking (radio)Adrenergic beta-AntagonistsPhysical ExertionPhysical exerciseElectromyographyPropranololSignalEndocrinologyHeart RateInternal medicineLactatesmedicineHumansβ adrenergic receptorPsychologyMuscle ContractionActa Physiologica Scandinavica
researchProduct

Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation.

2010

The aim of this study was to prepare and characterize both physically and biopharmaceutically, a nortriptyline hydrochloride (NTP-HCl) patch formulated in chitosan.16 g of each chitosan patch formulation (I, II and III, see Table 1 ) was poured onto rectangular glass plates (64 cm²) at a height of 1 mm and dried for 24 h at room temperature. In order to characterize the chitosan patches, polarized microscopy, in vitro skin permeation studies by passive diffusion and iontophoresis and rheological and bioadhesion studies were performed.Polarized microscopy revealed the absence of aggregates and crystal forms of NTP-HCl in all transdermal patches after 30 days of storage. The rheological behav…

AdultMaterials scienceTransdermal patchPharmaceutical ScienceTransdermal PatchNortriptylinePharmacologyAntidepressive Agents TricyclicChitosanchemistry.chemical_compoundHumansTransdermalSkinPolarized light microscopyChitosanIontophoresisAdrenergic Uptake InhibitorsGeneral MedicineAdhesionPermeationIontophoresisMiddle AgedchemistryChemical engineeringNortriptyline HydrochlorideFemaleSmoking CessationPharmaceutical development and technology
researchProduct